Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
Jiang C, Cheng G, Liao M, Huang J.
World J Surg Oncol. 2021 Mar 19;19(1):81. doi: 10.1186/s12957-021-02188-4.
PMID:33741001
Preemptive Septal Radiofrequency Ablation to Prevent Left Ventricular Outflow Tract Obstruction With Transcatheter Mitral Valve Replacement: A Case Series.
Killu AM, Collins JD, Eleid MF, Alkhouli M, Simard T, Rihal C, Asirvatham SJ, Guerrero M.
Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
Gu JH, Zhao QY, He C, Ye ZD, Xu M, Jiang TA.
Int J Hyperthermia. 2021;38(1):1092-1098. doi: 10.1080/02656736.2021.1943545.
PMID:34296656
Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas.
Li J, Zhang S, Ning C, Li G, Guo S.
Eur J Gastroenterol Hepatol. 2024 Jun 1;36(6):750-757. doi: 10.1097/MEG.0000000000002724. Epub 2024 Mar 28.
PMID:38555605
Transcatheter Arterial Chemoembolisation Combined with Radiofrequency Ablation on Hepatocellular Carcinoma and Levels of Relevant Markers.
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Liu W, Xu H, Ying X, Zhang D, Lai L, Wang L, Tu J, Ji J.
Med Sci Monit. 2020 Jul 15;26:e923263. doi: 10.12659/MSM.923263.
PMID:32667906
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
Chai B, Wang W, Wang F, Zhou G, Zheng C.
Int J Hyperthermia. 2021;38(1):1685-1694. doi: 10.1080/02656736.2021.1970825.